Detalhe da pesquisa
1.
Pharmacometric Analysis of the Relationship Between Absolute Lymphocyte Count and Expanded Disability Status Scale and Relapse Rate, Efficacy End Points, in Multiple Sclerosis Trials.
J Clin Pharmacol
; 58(10): 1284-1294, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29746722
2.
Application of Item Response Theory to Modeling of Expanded Disability Status Scale in Multiple Sclerosis.
AAPS J
; 19(1): 172-179, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27634384
3.
Polyethylene glycol-conjugated growth hormone-releasing hormone is long acting and stimulates GH in healthy young and elderly subjects.
Eur J Endocrinol
; 153(2): 249-56, 2005 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16061831
4.
Resistance Development: A Major Piece in the Jigsaw Puzzle of Tumor Size Modeling.
CPT Pharmacometrics Syst Pharmacol
; 4(6): 320-3, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26225260
5.
Pharmacometrics Markup Language (PharmML): Opening New Perspectives for Model Exchange in Drug Development.
CPT Pharmacometrics Syst Pharmacol
; 4(6): 316-9, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26225259
6.
A population model for the follicular growth in women treated with follicle stimulating hormone.
Clin Pharmacol Ther
; 62(6): 665-74, 1997 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-9433395
7.
Disposition and irreversible plasma protein binding of tolmetin in humans.
Clin Pharmacol Ther
; 44(1): 107-14, 1988 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-3390998
8.
Drug concentration response relationships in normal volunteers after oral administration of losartan, an angiotensin II receptor antagonist.
Clin Pharmacol Ther
; 51(5): 513-21, 1992 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-1587065
9.
Absence of metabolic effects of the topical carbonic anhydrase inhibitors MK-927 and sezolamide during two-week ocular administration to normal subjects.
Clin Pharmacol Ther
; 49(6): 665-73, 1991 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-2060255
10.
Pharmacokinetics and pharmacodynamics of IFN-beta 1a in healthy volunteers.
J Interferon Cytokine Res
; 20(10): 857-66, 2000 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-11054273
11.
Influence of interferon beta-1a dose frequency on PBMC cytokine secretion and biological effect markers.
J Neuroimmunol
; 99(1): 131-41, 1999 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-10496186
12.
Renal effects of nimesulide in furosemide-treated subjects.
Drugs
; 46 Suppl 1: 257-62, 1993.
Artigo
em Inglês
| MEDLINE | ID: mdl-7506186
13.
Clinical experience with angiotensin II receptor antagonists.
Am J Hypertens
; 5(12 Pt 2): 243S-246S, 1992 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-1290619
14.
Sinistrin clearance for determination of glomerular filtration rate: a reappraisal of various approaches using a new analytical method.
J Clin Pharmacol
; 37(8): 679-92, 1997 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-9378840
15.
Prevention of arrhythmias after noncardiac thoracic operations: flecainide versus digoxin.
Ann Thorac Surg
; 51(6): 964-7; discussion 967-8, 1991 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-1903918
16.
Leukemia inhibitory factor in human reproduction.
Fertil Steril
; 76(6): 1091-6, 2001 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-11730732
17.
Clinical pharmacology of recombinant human luteinizing hormone: Part I. Pharmacokinetics after intravenous administration to healthy female volunteers and comparison with urinary human luteinizing hormone.
Fertil Steril
; 69(2): 189-94, 1998 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-9496327
18.
Clinical pharmacology of recombinant human luteinizing hormone: Part II. Bioavailability of recombinant human luteinizing hormone assessed with an immunoassay and an in vitro bioassay.
Fertil Steril
; 69(2): 195-200, 1998 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-9496328
19.
Pharmacokinetic and pharmacodynamic interactions between recombinant human luteinizing hormone and recombinant human follicle-stimulating hormone.
Fertil Steril
; 69(2): 201-9, 1998 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-9496329
20.
Comparative pharmacokinetics and pharmacodynamics of recombinant human interferon beta-1a after intramuscular and subcutaneous administration.
Eur J Neurol
; 5(2): 187-193, 1998 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-10210831